6,305 results match your criteria: "Henoch-Schonlein Purpura Anaphylactoid Purpura"

Diffuse alveolar hemorrhage (DAH) is a rare and severe complication of IgA vasculitis (IgAV). Although glucocorticoids and immunosuppressive agents are used for its treatment, there is no consensus on the optimal form of treatment. We herein report the case of a 53-year-old, female patient with IgAV.

View Article and Find Full Text PDF

Monoclonal gammopathy of undetermined significance combined with renal damage is named monoclonal gammopathy of renal significance. There are few reports about IgA vasculitis in patients with monoclonal gammopathy of undetermined significance. Here, we report a case of monoclonal gammopathy of renal significance, who had manifestations of IgA vasculitis, including purpura, gastrointestinal bleeding and joint pain.

View Article and Find Full Text PDF

Background: Several cases of glomerular diseases following Covid-19 vaccination, especially mRNA vaccines, have been reported. However, there is little data on glomerular diseases associated with the two vaccines widely available in India (Covaxin and Covishield) and their long-term outcomes.

Materials And Methods: This was a prospective observational study conducted between May 2021 and May 2023.

View Article and Find Full Text PDF
Article Synopsis
  • - IgA vasculitis nephritis (IgAVN) is an immune disease primarily seen in children, often treated with corticosteroids and immunosuppressants, which can have serious side effects.
  • - Total glucosides of paeony (TGP), a natural compound derived from plants, has shown promise as a safer alternative treatment for IgAVN due to its low side effect profile and beneficial therapeutic mechanisms.
  • - This review discusses how TGP works through various pathways to combat IgAVN, including effects on inflammation and cell repair, and outlines recent developments aimed at improving its effectiveness and availability for future research.
View Article and Find Full Text PDF

Exploring the predictive factors in the gastrointestinal involvement of patients with immunoglobulin A vasculitis.

Turk J Pediatr

November 2024

Department of Pediatrics, Department of Pediatric Rheumatology, Faculty of Medicine, Kocaeli University, Kocaeli, Türkiye.

Article Synopsis
View Article and Find Full Text PDF
Article Synopsis
  • - This study investigates how TLR4/NF-κB/NLRP3 signaling impacts Henoch-Schonlein purpura nephritis (HSPN) using a rat model subjected to high-altitude hypoxia.
  • - Researchers used various techniques like H&E staining, immunohistochemistry, and flow cytometry to assess kidney damage and immune cell activity in the rats.
  • - The compound TAK-242 was found to reduce harmful signaling effects, decrease kidney damage, and improve immune responses, suggesting it may help in managing HSPN.
View Article and Find Full Text PDF

[Prognosis and risk factors of IgA vasculitis nephritis in children].

Zhonghua Er Ke Za Zhi

December 2024

Department of Pediatric Nephrology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan430030, China.

Article Synopsis
  • The study focused on understanding the prognosis and risk factors for children with IgA vasculitis nephritis (IgAVN) by analyzing clinical data from 264 diagnosed patients over more than three years.
  • Key findings revealed that the majority of patients presented with skin purpura and kidney issues such as hematuria and proteinuria, with most undergoing renal biopsies shortly after symptoms began.
  • Statistical analyses were employed to assess factors influencing prognosis, and results indicated that younger children had higher rates of complete remission after three years compared to older age groups.
View Article and Find Full Text PDF
Article Synopsis
  • * The study analyzed 28 patients, predominantly older adults (42.9% over 71 years), with a significant portion (53.6%) being women; previous infections were identified as triggers in 42.6% of cases, and the most common skin finding was palpable purpura (78.6%).
  • * Most patients required hospitalization (85.7%) for treatment, with an average stay of about 9.4 days,
View Article and Find Full Text PDF

Unlabelled: The aim of this study was to evaluate the cutaneous manifestations of immunoglobulin A vasculitis (IgAV) in terms of skin lesion type, distribution and persistence and to investigate the relationship between cutaneous manifestations and system involvement and treatment needs. This retrospective observational study was conducted with 489 IgAV patients who were followed-up for at least 6 months between 2013 and 2024. Demographic characteristics, detailed cutaneous manifestations, clinical findings and treatments were retrieved from electronic medical records.

View Article and Find Full Text PDF

Hospitalist-performed skin biopsy in the diagnosis of skin disease.

Arch Dermatol Res

November 2024

Department of General Internal Medicine, Akashi Medical Center, 743-33 Yagi, Ohkubo-cho, Akashi, Hyogo, 674-0063, Japan.

In hospitalized patients, dermatologist intervention can lead to rapid identification and treatment of skin disease. However, many medical centers lack a specialized dermatologist, so skin biopsies might instead be performed by hospitalists. We aimed to determine the impact of skin biopsies performed by hospitalists on the diagnosis of skin conditions.

View Article and Find Full Text PDF

Vasculitis in Children.

Turk Arch Pediatr

November 2024

Department of Pediatric Rheumatology, Hacettepe University Faculty of Medicine, Ankara, Türkiye.

Vasculitis in children represents a diverse group of diseases characterized by inflammation of blood vessels, which can lead to significant morbidity if not promptly recognized and managed. This review explores the epidemiology, pathophysiology, classification, and management of key pediatric vasculitides. Classification based on vessel size aids in diagnosis and treatment.

View Article and Find Full Text PDF

IgA vasculitis (IgAV), previously named as Henoch-Schönlein purpura, is the most frequent systemic vasculitis in children. In adults, IgAV is less common although it is associated with more severe disease. In fact, the frequency of glomerulonephritis (referred to as IgAV nephritis) in adults is higher than in children and tends to present more severely, with around 10-30% of those affected eventually progressing to end-stage renal disease.

View Article and Find Full Text PDF
Article Synopsis
  • Immunoglobulin A vasculitis (IgAV), formerly known as Henoch-Schönlein purpura, is the most common systemic vasculitis in children, affecting organs like the skin, gastrointestinal tract, joints, and kidneys.
  • GI involvement in IgAV varies from mild cases to severe ones requiring surgery, and while specific endoscopic findings can aid in diagnosis, not all cases present with dermatological symptoms like purpura.
  • Emerging evidence suggests that IgA enteropathy could be a variant of IgAV, as it shares similar symptoms and findings, highlighting the complex relationship between immune responses and clinical presentations in this condition.
View Article and Find Full Text PDF

Rationale: This article presents a complex case of refractory Henoch-Schönlein purpura (HSP), initially manifesting with complex gastrointestinal (GI) symptoms, and discusses diagnostic and therapeutic challenges encountered. It aims to enhance understanding of the disease and provide evidence for the potential efficacy of intravenous immunoglobulin (IVIG) treatment in this condition.

Patient Concerns: A 16-year-old male patient presented with persistent abdominal pain, nausea, vomiting, and constipation for 8 days, leading to hospital admission.

View Article and Find Full Text PDF

IgA vasculitis with nephritis: an overview of the pathogenesis and clinical characteristic.

Clin Exp Rheumatol

October 2024

Department of Nephrology, the Second Affiliated Hospital, Jiangxi Medical College, Nanchang University, Nanchang, Jiangxi, China.

IgA vasculitis with nephritis (IgAVN) is closely related to IgA nephritis (IgAN) and IgA vasculitis (IgAV), but the clinical characteristics and exact pathogenesis of IgAVN remain unclear. In the present study, we have reviewed 8 clinical trials with different treatments and found that most IgAVN patients had partial recovery after treatments while few patients (26.5%) recovered completely within 6 months.

View Article and Find Full Text PDF